Zone 2 cardio helps you live longer

In large studies that followed people for years, adults who did regular moderate aerobic activity, the range of effort that includes what is now called Zone 2, died at lower rates than adults who did little or none. Drawing on 94 cohorts with more than 30 million adults, about 75 minutes a week of moderate activity went with a 23 percent lower risk of death during follow-up, about 150 minutes with a 31 percent lower risk, and about 300 minutes with a 34 percent lower risk, with smaller and less certain differences beyond that. These studies observed people rather than assigning them to exercise, so they cannot separate the effect of the activity from the other ways active people differ, including being healthier to begin with.

Trials that randomly assigned exercise and counted deaths have not found an effect of that size. In the Generation 100 trial, 1,567 adults in Norway aged 70 to 77, most already fairly active, were assigned to five years of twice-weekly continuous training at about 70 percent of peak heart rate, which falls in or near the range usually described as Zone 2, to interval training at about 90 percent, or to national activity advice. Deaths did not differ between the combined exercise groups and the advice group. Across 29 trials of a year or more in adults over 60, mostly combining aerobic, strength and balance work, 7.1 percent of exercisers and 7.9 percent of comparison participants died, a difference the pooled analysis did not find statistically clear. A larger review of 93 trials of a year or more, in 28,523 adults aged 65 and over, also found no clear difference in deaths overall (a pooled risk 7 percent lower, within the range of chance), with a lower risk in the trials that enrolled people with an existing illness. In people with coronary heart disease, pooled trials of exercise-based cardiac rehabilitation found a likely small reduction in deaths over 6 to 12 months. No study has tested Zone 2 as it is defined today against death as an outcome.

Within the observational evidence, lower risk shows up at every intensity, and none of the comparisons cited here puts moderate activity ahead of vigorous: minute for minute, harder activity goes with the same or lower risk. In 116,221 US health professionals followed for 30 years, 150 to 299 minutes a week of moderate leisure activity went with a 19 to 25 percent lower risk of death, similar to 75 to 149 minutes of vigorous activity. The association was close to its largest at about 300 to 600 minutes a week of moderate activity or 150 to 300 of vigorous activity, with no clear further difference, and no sign of harm, above that. Among people already doing at least 300 minutes of moderate activity, adding vigorous activity did not go with lower risk; among people doing less, it did. A 2025 review of 20 studies, pooling nine cohorts for this comparison, found the lowest risk where vigorous activity made up roughly 30 to 60 percent of a person's moderate and vigorous activity, about 10 percent lower than where none of it was vigorous.

In eight cohorts where 36,383 mostly older adults wore activity monitors, light activity also went with lower risk: over a median of about six years, the most active quarter for light activity had 62 percent lower risk of death than the least active quarter, and the most active quarter for moderate-to-vigorous activity had 48 percent lower risk, each measured separately. A 2024 analysis of nine monitor cohorts, 46,682 adults followed for about nine years, separated how much people moved from how hard. The most active third had half the risk of death of the least active third. At the same total, the third doing the largest share at moderate-to-vigorous intensity had a 12 percent lower risk than the third doing the smallest share. In 147,414 German and British adults aged 40 to 74 who wore monitors, 150 minutes a week of moderate activity went with a 30 percent lower risk of death than none over about eight years, and the same difference appeared at about 510 minutes a week of light activity or about 12 minutes of vigorous activity. In a model that held total active time fixed, 15 to 60 minutes a week of vigorous activity in place of light or moderate activity went with an 18 to 30 percent lower risk. These are observations too, and people who move vigorously may differ in health from people who do not.

In Generation 100, deaths were 1.2 percentage points higher in the continuous training group and 1.7 points lower in the interval group than in the advice group, where 4.7 percent died. Neither difference was statistically clear, and the trial treated the comparison between the two exercise types as exploratory. People in the advice group did more of their own activity at high intensity than the continuous training group did. A 2025 review of the Zone 2 evidence found that the case for Zone 2 rests largely on observations of elite endurance athletes, and concluded that higher intensities appear to matter more for cardiometabolic health when total exercise time is low.

The death figures cover years of follow-up and do not describe the short-term cardiac risk during a session, which none of the sources here measured. The cardiac rehabilitation trials enrolled people mostly after a heart attack or a heart procedure, in structured programs, some based in a hospital or community center and some at home; women were 17 percent of participants. The World Health Organization's guidance states that people who are insufficiently active have a 20 to 30 percent higher risk of death than people who are sufficiently active and that both moderate and vigorous activity improve health, and it includes recommendations for people living with chronic conditions.